-
Forbion closes oversubscribed Fourth Life Sciences VC Fund at EUR 360million
October 1, 2018Naarden, The Netherlands, and Munich, Germany, 1 October 2018 – Forbion, a leading European life science venture capital firm,...
0 -
Forbion exceeds target with €270 million first close of its fourth life sciences VC fund
July 12, 2018Naarden, The Netherlands, and Munich, Germany, 11 July 2018 – Forbion, a leading European life science venture capital firm,...
-
Forbion Portfolio Company News: Dezima
September 12, 2014Dezima Reports Positive Results in its Phase 2b TULIP Trial with CETP Inhibitor TA-8995 in Dyslipidemia Combines outstanding efficacy...
-
Venture Capital in the Life Sciences Space the Time is NOW
September 12, 2014This 18 min video that was made of Sander van Deventer presenting at a Moscow Life Sciences Investment Day...
-
Forbion Portfolio Company News
April 4, 2014Forbion’s portfolio company Hookipa Biotech is winner of the Best Financing Deal Award in the Vaccine Industry Excellence (ViE)...
-
For Biotech and Beyond
April 3, 2014True innovation is driven by a small minority who are able to create precedent rather than follow it.